ST000774 Metabolic effects of novel aldehyde dehydrogenase inhibitors (ALDH) inhibitors
Limit by pathway class:
   Minimum # of metabolites per pathway:

Pathway name (# of metabolites detected in this study)HMDB pathwayKEGG pathway
Alanine Metabolism (1) SMP0000055 map00250
Ammonia Recycling (1) SMP0000009 map00910
beta-Alanine Metabolism (1) SMP0000007 map00410
Beta-Alanine Metabolism (1) SMP0000007 map00410
Biotin Metabolism (1) SMP0000066 map00780
Citric Acid Cycle (1) SMP0000057 map00020
Fatty Acid Biosynthesis (1) SMP0000456 -
Gluconeogenesis (1) SMP0000128 map00010
Glutamate Metabolism (1) SMP0000072 map00250
Nicotinate and Nicotinamide Metabolism (1) SMP0000048 map00760
Pantothenate and CoA Biosynthesis (1) SMP0000027 map00770
Propanoate Metabolism (1) SMP0000016 map00640
Pyruvate Metabolism (1) SMP0000060 map00620
Retinol Metabolism (1) SMP0000074 map00830
Riboflavin Metabolism (1) SMP0000070 map00740
Steroid Biosynthesis (1) SMP0000023 map00100
Thiamine Metabolism (1) SMP0000076 map00730
Threonine and 2-Oxobutanoate Degradation (1) SMP0000452 -
Transfer of Acetyl Groups into Mitochondria (1) SMP0000466 -
Valine, Leucine and Isoleucine Degradation (1) SMP0000032 map00280
Vitamin B6 Metabolism (1) SMP0000017 map00750
Vitamin K Metabolism (1) SMP0000464 -
Warburg Effect (1) SMP0000654 -
  logo